Healthcare provider profile · identity verified

Alian Hernandez Lopez

General Practice · HIALEAH, FL · NPI 1710333596

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Folic Acid	Folic Acid	363	54
Gabapentin	Gabapentin	350	106
Rosuvastatin Calcium	Rosuvastatin Calcium	350	194
Vitamin D2	Ergocalciferol (Vitamin D2)	306	87
Memantine Hcl	Memantine Hcl	287	63
Losartan Potassium	Losartan Potassium	269	142
Atorvastatin Calcium	Atorvastatin Calcium	261	149
Metformin Hcl	Metformin Hcl	248	127
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	222	56
Amlodipine Besylate	Amlodipine Besylate	187	106
Metoprolol Succinate	Metoprolol Succinate	169	93
Trazodone Hcl	Trazodone Hcl	163	40
Famotidine	Famotidine	152	77
Lisinopril	Lisinopril	147	78
Hydrochlorothiazide	Hydrochlorothiazide	145	75
Omeprazole	Omeprazole	145	76
Pantoprazole Sodium	Pantoprazole Sodium	144	70
Eliquis	Apixaban	142	33
Sertraline Hcl	Sertraline Hcl	132	34
Escitalopram Oxalate	Escitalopram Oxalate	125	36
Esomeprazole Magnesium	Esomeprazole Magnesium	123	63
Tadalafil	Tadalafil	118	29
Mirtazapine	Mirtazapine	114	35
Montelukast Sodium	Montelukast Sodium	111	58
Quetiapine Fumarate	Quetiapine Fumarate	109	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	104	26
Levothyroxine Sodium	Levothyroxine Sodium	101	57
Tamsulosin Hcl	Tamsulosin Hcl	93	54
Alprazolam	Alprazolam	92	25
Sildenafil Citrate	Sildenafil Citrate	90	20
Alendronate Sodium	Alendronate Sodium	87	43
Clopidogrel	Clopidogrel Bisulfate	87	42
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	85	27
Albuterol Sulfate Hfa	Albuterol Sulfate	74	27
Metoprolol Tartrate	Metoprolol Tartrate	73	42
Glimepiride	Glimepiride	67	34
Sure Comfort Pen Needle	Pen Needle, Diabetic	66	23
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	65	27
Buspirone Hcl	Buspirone Hcl	64	15
Alogliptin	Alogliptin Benzoate	63	15
Furosemide	Furosemide	63	39
Pioglitazone Hcl	Pioglitazone Hcl	63	13
Duloxetine Hcl	Duloxetine Hcl	62	13
Ezetimibe	Ezetimibe	58	15
Donepezil Hcl	Donepezil Hcl	56	18
Enalapril Maleate	Enalapril Maleate	56	24
Pentoxifylline	Pentoxifylline	56	12
Nifedipine Er	Nifedipine	55	28
Xarelto	Rivaroxaban	54	suppressed
Carvedilol	Carvedilol	49	27
Pregabalin	Pregabalin	49	12
Temazepam	Temazepam	48	13
Amitriptyline Hcl	Amitriptyline Hcl	47	suppressed
Ketoconazole	Ketoconazole	47	18
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	46	18
Latanoprost	Latanoprost	45	13
Clonazepam	Clonazepam	43	16
Januvia	Sitagliptin Phosphate	42	suppressed
Glipizide	Glipizide	41	23
Entresto	Sacubitril/Valsartan	40	suppressed
Glipizide Er	Glipizide	37	16
Finasteride	Finasteride	36	20
Fluticasone Propionate	Fluticasone Propionate	36	20
Chlorthalidone	Chlorthalidone	35	19
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Allopurinol	Allopurinol	34	16
Insulin Aspart Prot Mix 70-30	Insulin Aspart Prot/Insuln Asp	34	suppressed
Valsartan	Valsartan	34	12
Azithromycin	Azithromycin	32	31
Levetiracetam	Levetiracetam	32	suppressed
Simvastatin	Simvastatin	30	14
Atenolol	Atenolol	29	18
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Benzonatate	Benzonatate	27	25
Ranolazine Er	Ranolazine	27	suppressed
Trueplus Insulin Syringe	Syringe And Needle,insulin,1ml	27	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	17
Lactulose	Lactulose	25	14
Hydroxyurea	Hydroxyurea	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	16
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	12
Brilinta	Ticagrelor	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	13
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Irbesartan	Irbesartan	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Prednisone	Prednisone	20	12
Ammonium Lactate	Ammonium Lactate	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Risedronate Sodium	Risedronate Sodium	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Sotalol	Sotalol Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	14
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	16	suppressed
Naproxen	Naproxen	16	15
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Methocarbamol	Methocarbamol	15	15
Amantadine	Amantadine Hcl	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Ibuprofen	Ibuprofen	14	11
Myrbetriq	Mirabegron	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Mupirocin	Mupirocin	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Baclofen	Baclofen	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error